Evidence map›Paper›PMID 41266380›Full record

ArticleScientific data2025

MU-Glioma Post: A comprehensive dataset of automated MR multi-sequence segmentation and clinical features.

Esmat Mahmoud, Jaime Gass, Yaseen Dhemesh, Josh Greaser, Karolina Pogorzelski, Edvin Isufi, Filip Garrett, Jonathan Thacker, Nourel Hoda Tahon, Jason Sinclair and 3 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Esmat Mahmoud *Diagnostic and Interventional Radiology, National Cancer Institute, Cairo University, Cairo, Egypt.
Jaime Gass *Radiology Department, University of Missouri, Columbia, MO, USA.
Yaseen Dhemesh *Department of Medicine, Washington University in Saint Louis, St. Louis, MO, USA.
Josh Greaser *Radiology Department, University of Missouri, Columbia, MO, USA.ORCID 0009-0007-1091-194X
Karolina PogorzelskiRadiology Department, University of Missouri, Columbia, MO, USA.ORCID 0009-0000-0094-7577
Edvin IsufiRadiology Department, University of Missouri, Columbia, MO, USA. edvin.isufi@health.missouri.edu.
Filip GarrettPathology Department, University of Missouri, Columbia, MO, USA.
Jonathan ThackerRadiology Department, University of Missouri, Columbia, MO, USA.
Nourel Hoda TahonRadiology Department, University of Texas, Houston, TX, USA.ORCID 0009-0002-5863-0219
Jason SinclairPathology Department, University of Missouri, Columbia, MO, USA.
Lester LayfieldPathology Department, University of Missouri, Columbia, MO, USA.
Talissa AltesRadiology Department, University of Missouri, Columbia, MO, USA.
Ayman NadaMallinckrodt Institute of Radiology, School of Medicine, Washington University in Saint Louis, St. Louis, MO, USA. anada@wustl.edu.ORCID 0000-0002-9296-9227

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliomas represent a heterogenous group of primary brain tumors with overlapping imaging phenotypes. Treatment typically includes surgery and/or chemoradiation, however this varies based on the overall lesion and clinical presentation. This heterogeneity in both lesion characteristics and management strategies contributes to a lack of reliable findings when evaluating treatment outcomes with conventional MRI. The overlapping imaging features of radiation necrosis and tumor progression post-treatment can be particularly challenging for radiologists. We present a dataset of 203 glioma patients with 594 post-treatment timepoints of relevant clinical history and routine T1, T1 postcontrast, T2, and FLAIR weighted MR sequences. Preprocessing of the images follow a standardized pipeline with automatic deep-learning based segmentations for each tumor component i.e. enhancing tumor, non-enhancing necrotic core, surrounding non-enhancing FLAIR signal hyperintensity, and resection cavity. The automatic segmentations were manually validated and refined by neuroradiologists to get the ground truth labels. Our contribution of this robust dataset to an open-source repository aims to contribute to the development of AI models to improve evaluation of treatment outcomes.

Indexed as

Brain NeoplasmsGliomaMagnetic Resonance ImagingDeep LearningHumans

Identifiers

PMID41266380
PMCPMC12635165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.